...Euronext:DBV; NASDAQ:DBVT) 4/3/19 $70.4 $477.6 $581.6 22% Advaxis Inc. (NASDAQ:ADXS) 4/3/19 $10.0 $32.0 $16.8 -48% Pluristem Therapeutics Inc....

...The NASA Ames Research Center will study the potential of placenta-based PLX cell therapies from Pluristem Therapeutics Inc....
...allogeneic placental-derived expanded (PLX) cells, for promoting muscle regeneration and to treat radiation-induced conditions, respectively. Pluristem Therapeutics Inc....
...Haifa, Israel NASA Ames Research Center, Moffett Field, Calif. Business: Other, Cardiovascular Sandi Wong PLX-PAD cells PLX-RAD cells (PLX-R18) Pluristem Therapeutics Inc. muscle...

...can commercialize the product and take it to patients.” Christopher Anzalone, Arrowhead Stem cell company Pluristem Therapeutics Inc....
...SIX:NOVN), Basel, Switzerland Novelion Therapeutics Inc. (NASDAQ:NLVN), Vancouver, Canada Orchard Therapeutics Ltd. (NASDAQ:ORTX), London, U.K. Pluristem Therapeutics Inc....
...NASDAQ:PTCT), South Plainfield, N.J. Valneva SE (Euronext:VLA), Lyon, France Erin McCallister, Senior Editor Alkahest Inc. Arrowhead Pharmaceuticals Inc. ImmusanT Inc. Pluristem Therapeutics Inc. Valneva...

...charge payment for an expanded access program for critical limb ischemia (CLI) candidate PLX-PAD from Pluristem Therapeutics Inc....
...trial for CLI. The allogeneic, placental-derived expanded (PLX) cells have Fast Track designation from FDA. Pluristem Therapeutics Inc....
...NASDAQ:PSTI; Tel Aviv:PSTI), Haifa, Israel WideTrial Inc., San Francisco, Calif. Business: Other, Cardiovascular Elizabeth S. Eaton PLX-PAD cells Pluristem Therapeutics Inc. cost...

...charge payment for an expanded access program for critical limb ischemia (CLI) candidate PLX-PAD from Pluristem Therapeutics Inc....
...CLI. The allogeneic, placental-derived expanded (PLX) cells have Fast Track designation from FDA. Elizabeth S. Eaton PLX-PAD cells Pluristem Therapeutics Inc. expanded...

...abundant, natural source of tissues that can be transferred allogeneically. According to BioCentury’s BCIQ database, Pluristem Therapeutics Inc....
...Longevity Inc., San Diego, Calif. NantKwest Inc. (NASDAQ:NK), San Diego, Calif. PepsiCo (NASDAQ:PEP), Purchase, N.Y. Pluristem Therapeutics Inc....

...A) 11/1/17 $8.0 NA $25.8 NA Intellia Therapeutics Inc. (NASDAQ:NTLA) 11/1/17 $150.0 $1,016.1 $813.7 -20% Pluristem Therapeutics Inc....

...On June 20, Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) disclosed that plans had been terminated for the company...
...allogeneic, placental-derived expanded (PLX) cells. Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI), Haifa, Israel Business: Cardiovascular Mary Romeo PLX cells PLX-PAD cells Pluristem Therapeutics Inc....

...company's shares have gained $0.07 to $1.39 on NASDAQ and added NIS18.50 to NIS475.10. Paul Bonanos PLX-PAD cells Pluristem Therapeutics Inc....

...Inc. (NASDAQ:OCUL) 1/24/17 $25.0 $201.3 $266.9 33% Affimed N.V. (NASDAQ:AFMD) 1/20/17 $19.2 $79.0 $99.5 26% Pluristem Therapeutics Inc....